2024

• Parker, M., Jee, A., Hansen, D., Proudman, S., Youssef, P., Kenna, T., Stevens, W., Nikpour, M., Sahhar, J., Corte, T. (2024). Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology, 63(11), 2981-2988. [More Information]
• Littlejohn, G., Leadbetter, J., Butcher, B., Feletar, M., O’Sullivan, C., Smith, T., Witcombe, D., Ng, H., Youssef, P. (2024). Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical Rheumatology. [More Information]
• Ciciriello, S., Deakin, C., Littlejohn, G., Treuer, T., Gibson, K., Haladyj, E., Youssef, P., Bird, P., O'Sullivan, C., Smith, T. (2024). Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset. Clinical and Experimental Rheumatology, 42(9), 1763-1772. [More Information]

2023

• Jee, A., Stewart, I., Youssef, P., Adelstein, S., Lai, D., Hua, S., Stevens, W., Proudman, S., Ngian, G., Glaspole, I., Corte, T., et al (2023). A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study. Arthritis & Rheumatology, 75(8), 1424-1433. [More Information]
• Tymms, K., O'Sullivan, C., Smith, T., Littlejohn, G., Freeman, T., Hoffman, D., Segelov, D., Griffiths, H., Ciciriello, S., Youssef, P., et al (2023). A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience. Frontiers in Digital Health, 4. [More Information]
• Deakin, C., De Stavola, B., Littlejohn, G., Griffiths, H., Ciciriello, S., Youssef, P., Mathers, D., Bird, P., Smith, T., O'Sullivan, C., et al (2023). Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia. JAMA Network Open, 6(6), E2320851. [More Information]
• Deakin, C., Littlejohn, G., Griffiths, H., Ciciriello, S., O'Sullivan, C., Smith, T., Youssef, P., Bird, P. (2023). Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings. Internal Medicine Journal. [More Information]
• Ciciriello, S., Littlejohn, G., Treuer, T., Gibson, K., Haladyj, E., Youssef, P., Bird, P., O'Sullivan, C., Smith, T., Deakin, C. (2023). Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set. ACR Open Rheumatology, 5(7), 345-353. [More Information]

2022

• Hanna, S., Youssef, P., Lowe, P. (2022). Novel combination biologic therapy for recalcitrant psoriasis and psoriatic arthritis in a medically complex patient. Australasian Journal of Dermatology, 63(1), e63-e66. [More Information]
• Caterson, H., Youssef, P. (2022). Sulfasalazine-induced myopathy in a patient with an acute spondyloarthritis. Internal Medicine Journal, 52(1), 155. [More Information]

2020

• Sammel, A., Hsiao, E., Schembri, G., Bailey, E., Nguyen, K., Brewer, J., Schrieber, L., Janssen, B., Youssef, P., Fraser, C., Laurent, R. (2020). Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis. International Journal of Rheumatic Diseases, 23(4), 582-588. [More Information]
• Ross, L., Stevens, W., Wilson, M., Huq, M., Strickland, G., Walker, J., Sahhar, J., Ngian, G., Roddy, J., Youssef, P., et al (2020). Performance of the 2017 EUSTAR activity index in an scleroderma cohort. Clinical Rheumatology, 39(12), 3701-3705. [More Information]
• Youssef, P., Marcal, B., Button, P., Truman, M., Bird, P., Griffiths, H., Roberts, L., Tymms, K., Littlejohn, G. (2020). Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset. Journal of Rheumatology, 47(8), 1174-1181. [More Information]

2019

• Sammel, A., Hsiao, E., Schembri, G., Nguyen, K., Brewer, J., Schrieber, L., Janssen, B., Youssef, P., Fraser, C., Bailey, E., Bailey, D., Roach, P., Laurent, R. (2019). Diagnostic Accuracy of Positron Emission Tomography/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double-Blind, Cross-Sectional Study. Arthritis & Rheumatology, 71(8), 1319-1328. [More Information]
• Jee, A., Sahhar, J., Youssef, P., Bleasel, J., Adelstein, S., Nguyen, M., Corte, T. (2019). Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons. Pharmacology & Therapeutics, 202, 40-52. [More Information]

2018

• Jones, G., Hall, S., Bird, P., Littlejohn, G., Tymms, K., Youssef, P., Chung, E., Barrett, R., Button, P. (2018). A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population. International Journal of Rheumatic Diseases, 21(8), 1581-1590. [More Information]
• Tymms, K., Littlejohn, G., Griffiths, H., de Jager, J., Bird, P., Joshua, F., Nash, P., Handel, M., McManus, H., Butcher, B., Youssef, P. (2018). Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors. Clinical Rheumatology, 37(6), 1617-1623. [More Information]

2017

• Sammel, A., Hsiao, E., Schrieber, L., Janssen, B., Youssef, P., Fraser, C., Kuo, C., Dunn, H., Bailey, D., Roach, P., Schembri, G., Laurent, R., et al (2017). Fluorine-18 Fluoro-2-Deoxyglucose Positron Emission Tomography Uptake in the Superficial Temporal and Vertebral Arteries in Biopsy Positive Giant Cell Arteritis. International Journal of Clinical Rheumatology, 23(8), 443. [More Information]
• Boulos, D., Ngian, G., RAJADURAI, A., Elford, K., Stevens, W., Proudman, S., Owen, C., Roddy, J., Nikpour, M., Youssef, P., et al (2017). Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. International Journal of Rheumatic Diseases, 20(4), 481-488. [More Information]
• Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T., Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017). Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate? Internal Medicine Journal, 47(10), 1124-1128. [More Information]
• Jee, A., Adelstein, S., Bleasel, J., Keir, G., Nguyen, M., Sahhar, J., Youssef, P., Corte, T. (2017). Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine, 6(5), 1-23. [More Information]

2016

• Owen, C., Ngain, G., Elford, K., Moore, O., Stevens, W., Nikpour, M., Rabusa, C., Proudman, S., Roddy, J., Youssef, P., et al (2016). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Clinical and Experimental Rheumatology, 34(Suppl. 100), S170-S176.
• Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., Walker, J., Roddy, J., Lester, S., Rischmueller, M., Youssef, P., et al (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(Suppl 100), 129-136.

2015

• Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(7), 1-11. [More Information]
• Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140. [More Information]
• Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., Morrisroe, K., Thakkar, V., Sahhar, V., Roddy, J., Youssef, P., et al (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(Suppl 91), S111-S116.

2014

• Nicholls, D., Zochling, J., Boers, A., Champion, G., Mathers, D., Riordan, J., Youssef, P., Scott, J., Griffiths, H. (2014). A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice. International Journal of Rheumatic Diseases, 17(7), 755-761. [More Information]

2013

• Moore, O., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., Byron, J., Sahhar, J., Gabbay, E., Youssef, P., et al (2013). Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology, 52(1), 155-160. [More Information]
• Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R., Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening and Treating Pulmonary Arterial Hypertension in a Tertiary Hospital-based Multidisciplinary Clinic: The First 200 Patients. Internal Medicine Journal, 43(1), 32-37. [More Information]
• Lord, M., Day, A., Youssef, P., Zhuo, L., Watanabe, H., Caterson, B., Whitelock, J. (2013). Sulfation of the Bikunin Chondroitin Sulfate Chain Determines Heavy Chain - Hyaluronan Complex Formation. Journal of Biological Chemistry, 288(32), 22930-22941. [More Information]
• Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., Roddy, J., Walker, J., Zochling, J., Sahhar, J., et al (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research and Therapy, 15(6), 1-11. [More Information]

2012

• Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy, 14(3), 1-10. [More Information]
• Lord, M., Estrella, R., Chuang, C., Youssef, P., Karlsson, N., Flannery, C., Whitelock, J. (2012). Not All Lubricin Isoforms Are Substituted with a Glycosaminoglycan Chain. Connective Tissue Research, 53(2), 132-141. [More Information]

2011

• Craig, S., Youssef, P., Vaile, J., Sullivan, L., Bleasel, J. (2011). Intravenous Zoledronate and Oral Alendronate in Patients with a Low Trauma Fracture: experience from an osteoporosis clinic. Internal Medicine Journal, 41(2), 186-190. [More Information]

2007

• Richards, B., Spies, J., McGill, N., Richards, G., Vaile, J., Bleasel, J., Youssef, P. (2007). Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Internal Medicine Journal, 37, 101-107. [More Information]

2005

• Youssef, P., Hsu, K., Passey, R., Endoh, Y., Rahimi, F., Yen, T., Geczy, C. (2005). Regulation of S100A8 by glucocorticoids. Journal of Immunology, 174(4), 2318-26. [More Information]